Literature DB >> 32407531

ROHHAD(NET) Syndrome: Systematic Review of the Clinical Timeline and Recommendations for Diagnosis and Prognosis.

Julie Harvengt1, Caroline Gernay2, Meriem Mastouri3, Nesrine Farhat4, Marie-Christine Lebrethon2, Marie-Christine Seghaye4, Vincent Bours1.   

Abstract

CONTEXT: Rapid-onset obesity with hypothalamic dysfunction, hypoventilation, autonomic dysregulation and neural crest tumor (ROHHHAD[NET]) is a rare and potentially fatal disease. No specific diagnostic biomarker is currently available, making prompt diagnosis challenging. Since its first definition in 2007, a complete clinical analysis leading to specific diagnosis and follow-up recommendations is still missing.
OBJECTIVE: The purpose of this work is to describe the clinical timeline of symptoms of ROHHAD(NET) and propose recommendations for diagnosis and follow-up.
DESIGN: We conducted a systematic review of all ROHHAD(NET) case studies and report a new ROHHAD patient with early diagnosis and multidisciplinary care.
METHODS: All the articles that meet the definition of ROHHAD(NET) and provide chronological clinical data were reviewed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis individual patient data guidelines. The data were grouped into 7 categories: hypothalamic dysfunction, autonomic dysregulation, hypoventilation, NET, psychiatric symptoms, other clinical manifestations, and outcome.
RESULTS: Forty-three individual patient data descriptions were analyzed. The timeline of the disease shows rapid-onset obesity followed shortly by hypothalamic dysfunction. Dysautonomia was reported at a median age of 4.95 years and hypoventilation at 5.33 years, or 2.2 years after the initial obesity. A NET was reported in 56% of the patients, and 70% of these tumors were diagnosed within 2 years after initial weight gain.
CONCLUSION: Because early diagnosis improves the clinical management and the prognosis in ROHHAD(NET), this diagnosis should be considered for any child with rapid and early obesity. We propose guidance for systematic follow-up and advise multidisciplinary management with the aim of improving prognosis and life expectancy. © Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  ROHHAD; central hypoventilation; dysautonomia; neural crest tumor; precocious obesity; sinusal bradycardia

Mesh:

Year:  2020        PMID: 32407531     DOI: 10.1210/clinem/dgaa247

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

Review 1.  Hypothalamic syndrome.

Authors:  Hermann L Müller; Maithé Tauber; Elizabeth A Lawson; Jale Özyurt; Brigitte Bison; Juan-Pedro Martinez-Barbera; Stephanie Puget; Thomas E Merchant; Hanneke M van Santen
Journal:  Nat Rev Dis Primers       Date:  2022-04-21       Impact factor: 52.329

2.  A novel case of central hypoventilation syndrome or just heavy breathing?

Authors:  Jacob McCoy; Natalya Karp; Jagraj Brar; Reshma Amin; Aaron St-Laurent
Journal:  J Clin Sleep Med       Date:  2022-09-01       Impact factor: 4.324

Review 3.  Autoimmunity Related to Adipsic Hypernatremia and ROHHAD Syndrome.

Authors:  Akari Nakamura-Utsunomiya
Journal:  Int J Mol Sci       Date:  2022-06-21       Impact factor: 6.208

Review 4.  Adrenal ganglioneuroma: Prognostic factors (Review).

Authors:  Florica Sandru; Mihai Cristian Dumitrascu; Aida Petca; Mara Carsote; Razvan-Cosmin Petca; Ana Maria Oproiu; Adina Ghemigian
Journal:  Exp Ther Med       Date:  2021-09-22       Impact factor: 2.751

5.  Thoracic Ganglioneuroma Presenting with Paraneoplastic Cerebellitis and ROHHAD-NET Syndrome.

Authors:  Sarbesh Tiwari; Mufeed Arimbrakkunnan; Taruna Yadav; Varuna Vyas; Kirti K Rathod; Vikarn Vishwajeet
Journal:  Ann Indian Acad Neurol       Date:  2022-02-08       Impact factor: 1.714

6.  ZSCAN1 Autoantibodies Are Associated with Pediatric Paraneoplastic ROHHAD.

Authors:  Caleigh Mandel-Brehm; Leslie A Benson; Baouyen Tran; Mark P Gorman; Joseph L DeRisi; Andrew F Kung; Sabrina A Mann; Sara E Vazquez; Hanna Retallack; Hannah A Sample; Kelsey C Zorn; Lillian M Khan; Lauren M Kerr; Patrick L McAlpine; Lichao Zhang; Frank McCarthy; Joshua E Elias; Umakanth Katwa; Christina M Astley; Stuart Tomko; Josep Dalmau; William W Seeley; Samuel J Pleasure; Michael R Wilson
Journal:  Ann Neurol       Date:  2022-05-25       Impact factor: 11.274

7.  ROHHAD syndrome without rapid-onset obesity: A diagnosis challenge.

Authors:  Blandine Desse; Antoine Tran; Mathilde Butori; Sarah Marchal; Michael Afanetti; Sébastien Barthélemy; Etienne Bérard; Elisabeth Baechler; Stéphane Debelleix; Marie-Emilie Lampin; Julie Macey; Bruno Massenavette; Julie Harvengt; Ha Trang; Lisa Giovannini-Chami
Journal:  Front Pediatr       Date:  2022-08-31       Impact factor: 3.569

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.